Nature and Wiley expand portfolios

Share this article:
Pieter van der Graaf
Pieter van der Graaf

The American Society for Clinical Pharmacology and Therapeutics is launching its first fully open-access publication. CPT: Pharmacometrics & Systems Pharmacology will be published by ASCPT with the Nature Publishing Group. While this is a new format for ASCPT,  NPG has considerable experience in the area: their website says about 90% of the academic and society journals that they publish are open-access.

The new publication, which will be referred to in short-hand as CPT:PSP, will focus on original research in advances in quantitative methods as they are applied in pharmacology, physiology and therapeutics in humans. Articles will be covered by a Creative Commons license, which means that readers will be able to download and share them, and that the authors will be assessed a per-article processing fee for submissions. ASCPT told MM&M that advertising will support the subscription-free service. “I think this is a great opportunity for our discipline and recognition of its continuously growing impact in clinical pharmacology and drug development,” CPT:PSP Editor-in-Chief Pieter van der Graaf said in a statement.

Mega-publisher Wiley-Blackwell is expanding its reach as well, with the addition of 44 journals to its portfolio. The portfolio expansion includes 16 new-to-market titles, as well as 28 that are coming over from other publishers or were originally self-published. Wiley will be publishing the majority of the new journals as a partner with several societies and organizations. These titles include European Journal of Pain, Pharmacotherapy, The Journal of Human Pharmacology and Drug Therapy and Biology of the Cell.

The new catalogue will also increase the Wiley Open Access program by eight titles, including The Journal of the American Hearth Association: Cardiovascular and Cerebrovascular, Cancer Medicine and Food and Energy Security.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?